Furthermore, in our study, we have demonstrated that canertinib and afatinib could influence pancreatic cancer cell migration, as FAK is regarded as the initiator of cell migration and cancer metastasis [46]. The gene discussed is PTK2; the disease is familial pancreatic carcinoma.